title: Gastrointestinal stromal tumour in a recipient with kidney transplantation.
abstract: Immunosuppression is associated with an increased risk of post-transplant malignancies. Gastrointestinal stromal tumours are the most common mesenchymal tumours of the gastrointestinal tract. However, they have seldom been reported recipient with transplantation. In this report, a 46-year-old woman, a recipient with kidney transplantation, who developed a gastric tumour is presented. Removal of this tumour required a partial gastrectomy. Histopathology and immunohistochemistry examinations revealed a high-risk gastric stromal tumour. Adjuvant imatinib mesylate treatment was initiated. There was no evidence of tumour recurrence at 12-month follow-up.
authors.affiliation: Department of Surgery, Dalhousie University, Halifax, Canada.
authors.forename: Sertac
authors.initials: S
authors.lastname: Cimen
authors.affiliation: Department of Surgery, Dalhousie University, Halifax, Canada.
authors.forename: Sanem
authors.initials: S
authors.lastname: Guler
authors.affiliation: Department of Nephrology, Dalhousie University, Halifax, Canada.
authors.forename: Romuald
authors.initials: R
authors.lastname: Panek
authors.affiliation: Department of Surgery, Dalhousie University, Halifax, Canada.
authors.forename: Ian
authors.initials: I
authors.lastname: Alwayn
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D005260:Female; D005743:Gastrectomy / Q000379:methods*; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate